1Gupta K, Hooton T M,Stamm W E. Increasing antimicrobial resistance and the management of uncomplicated community--acquired urinary tract infections[J]. Ann Intern Meal,2001,135(1):41--50.
2Warren J W, Abrutyn E, Hebel J R , et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women[J]. Clin Infect Dis, 1999,29 : 745-- 758.
3Lindsay N, Peter A M, Anderson J C, et al. Uncomplicated urinary tract infection in women current practice and the effect of antibiotic resistance on empiric treatment[J]. Can Fam Physician, 2006, 52 (5) : 612--618.
4Wagenlehner F M, Weidner W, Naber K G. An update on uncomplicared urinary tract infections in women[J]. Curr Opin Urol, 2009, 19(4) : 368-374.
5Guay D R. Contemporary management of uncomplicated urinary tract infections[J]. Drugs, 2008,68 (9) : 1169 -- 1205.
6SA Mehnert--Kay. Diagnosis and management of uncomplicated urinary tract infections [J]. Am Fam Physician, 2005,72 (3) : 451 -- 456.
7Tu Y, McCalla D R. Effect of activated nitrofurans on DNA[J]. Biochim Biophys Acta, 1975,402(2) : 142 -- 149.
8Cendron M. Antibiotic prophylaxis in the management of vesicoureteral reflux[J]. Adv Urol, 2008 : 825475.
9Ertan G, Karasulu E, Abou--Nada M, et al. Sustained--release dosage form of nitrofurantoin. Part 2. In vivo urinary excretion in man[J]. J Microeneapsul, 1994,11 (2) : 137-140.
10Johnson J R, Berggren T, Conway A J. Activity of a nitrofurazone matrix urinary catheter against catheter-- associated uropathogens [J]. Antimicrob Agents Chemother,1993,37(9) :2033--2036.
